The NHLBI Small Business Program enables US-owned and operated small businesses to engage in research and development on innovative and commercially promising products and services to prevent, diagnose, and treat heart, lung, and blood-related diseases and disorders.
Funding for small business research is available through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) mechanisms. For an overview of these mechanisms, please visit ABOUT THE PROGRAMS. You can also explore current NHLBI SBIR/STTR funding opportunities here.
Staff from the NHLBI Office of Translational Alliances and Coordination (OTAC), are available to advise and mentor NHLBI SBIR/STTR applicants and awardees on matters relating to product development, regulatory affairs, intellectual property, product commercialization, licensing, and strategic partnerships.
Seek NHLBI guidance while writing your Bridge and Small Market Applications
Applications due June 19, 2017
Apply for up to $3M to support continued development of your Phase II SBIR or STTR-funded heart, lung, blood, or sleep technology requiring approval or clearance by a Federal regulatory agency. The NHLBI SBIR Phase IIB Bridge and Small Market Awards programs aim to de-risk your technology and encourage partnerships between small businesses and investors and strategic partners.
Letters of Intent due May 19, 2017. Applications due June 19, 2017.
For more information on how to respond, please read the full Notice:
Get Tips on Your Commercialization Plan and Regulatory Strategy
Watch the NHLBI Small Biz Hangouts. Check out archived presentations
Last Updated February 2017